help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 16, 2006
Endocrinology, doi:10.1210/en.2005-0853
A more recent version of this article appeared on May 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/5/2287    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, N.
Right arrow Articles by Chua, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, N.
Right arrow Articles by Chua, S., Jr
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE

Submitted on July 9, 2005
Accepted on February 8, 2006

Allelic variation on chromosome 5 controls beta cell mass expansion during hyperglycemia in leptin receptor deficient diabetes mice

Na Luo, Shun Mei Liu, Hong Liu, Qiong Li, Qun Xu, Xi Sun, Brandi Davis, Jing Li, and Streamson Chua Jr*

Institute of Human Nutrition, Columbia University, 630 West 168Street, New York, NY 10032; Division of Molecular Genetics, Department of Pediatrics, Columbia University, 1150 St. Nicholas Avenue, New York, NY 10032; Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York, NY 10461

* To whom correspondence should be addressed. E-mail: schua{at}aecom.yu.edu.

Leptin signaling is a critical component of normal insulin sensitivity. Overt hyperglycemia and Type 2 diabetes mellitus can be manifested in states of leptin signaling deficiencies by the additional effects of other genetic factors. We have previously described the contrasting insulin sensitivities and glycemic states of two congenic diabetes (db/db) mouse strains. C57BL/6J db/db mice have mild insulin resistance and achieve euglycemia with mild hyperinsulinemia. FVB db/db mice have severe insulin resistance and are hyperglycemic despite escalating hyperinsulinemia with expanded pancreatic {beta} cell mass. Analysis of obese progeny from the two reciprocal backcrosses suggests that genetic modifiers for insulin sensitivity are separable from loci that modulate {beta} cell mass. A genome scan of the backcross to FVB suggests that one or more modifier genes are present on Chromosome 5. This evidence is supported by the phenotypes of multiple incipient congenic strains wherein the hyperglycemia observed in obese FVB mice is reproduced. With similar degrees of hyperglycemia in obese mice of these strains, the haplotype at chromosome 5 is associated with {beta} cell mass and circulating insulin concentrations. Finally, we offer arguments that production of multiple incipient congenic lines is an economical alternative to the production of speed congenic strains.


Key words: leptin receptor • diabetes • {beta} cell mass • hyperglycemia • modifier genes




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. M. Clee and A. D. Attie
The Genetic Landscape of Type 2 Diabetes in Mice
Endocr. Rev., February 1, 2007; 28(1): 48 - 83.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society